作者：
Changhoon,Yoo [1]
;
Milind M,Javle [2]
;
Helena,Verdaguer Mata [3]
;
Filippo,de Braud [4]
;
Jörg,Trojan [5]
;
Jean-Luc,Raoul [6]
;
Jin Won,Kim [7]
;
Makoto,Ueno [8]
;
Choong-Kun,Lee [9]
;
Susumu,Hijioka [10]
;
Antonio,Cubillo [11]
;
Junji,Furuse [8]
;
Nilofer,Azad [12]
;
Masashi,Sato [13]
;
Yulia,Vugmeyster [14]
;
Andreas,Machl [14]
;
Marcis,Bajars [15]
;
John,Bridgewater [16]
;
Do-Youn,Oh [17]
;
Mitesh J,Borad [18]
作者单位：
Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
[1]
The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
[2]
Vall d'Hebron University Hospital, Barcelona, Spain.
[3]
IRCCS National Cancer Institute Foundation, Milan, Italy.
[4]
Goethe University Hospital, Frankfurt, Germany.
[5]
ICO- Site René Gauducheau, Saint-Herblain, France.
[6]
Seoul National University Bundang Hospital, Seongnam, South Korea.
[7]
Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
[8]
Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
[9]
National Cancer Center Hospital, Chuo, Tokyo, Japan.
[10]
HM Madrid Sanchinarro University Hospital, Clara Campal Comprehensive Cancer Center, Madrid, Spain.;UCJC HM Hospital School of Health Sciences, Madrid, Spain.
[11]
The Johns Hopkins Hospital, Baltimore, Maryland, USA.
[12]
Merck Biopharma Co., Ltd., Tokyo, Japan, an affiliate of Merck KGaA, Darmstadt, Germany.
[13]
EMD Serono, Billerica, Massachusetts, USA.
[14]
The Healthcare Business of Merck KGaA, Darmstadt, Germany.
[15]
UCL Cancer Institute, London, UK.
[16]
Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea.
[17]
Mayo Clinic Cancer Center, Phoenix, Arizona, USA.
[18]
DOI
10.1097/HEP.0000000000000365
PMID
36999533
发布时间
2024-09-23
换一批
换一批
